VAD-Destination Therapy or Bridge?
Ventricular Assist Devices. Present and future
With arnis and sglt2, how can we manage polipharmacy in hf?
MARCELO DI CARLI
How imaging change the treatment paradigm in cardiomyopathies
JOHN MC MURRAY
New Trials in Heart Failure.Where are we at the end of 2020
Iron Deficiency in Heart Failure
Quadruple Therapy as the new standard of care in heart failure with reduced EF
pre and post capillary pulmonary hypertension. upfront therapy?
Drug and devices in the treatment of hfpef. new options
support in pulmonary hypertension in advanced right heart failure
End stage hf patients keep need to keep or remove CRT-d?